N-Nitroso Fluvoxamine EP Impurity K
N-Nitroso Fluvoxamine EP Impurity K is a specific impurity associated with the drug fluvoxamine, which is an antidepressant medication. In pharmaceutical contexts, impurities like N-Nitroso Fluvoxamine EP Impurity K are closely monitored because they can affect the efficacy, safety, and stability of the drug product.Pharmaceutical companies use analytical methods to monitor and control the levels of N-Nitroso Fluvoxamine EP Impurity K during the manufacturing process and in finished drug products.
N-Nitroso Fluvoxamine EP Impurity K CAS NO:NA also Known as N-Nitroso Fluvoxamine Impurity K chemically represented as (E)-N-(2-aminoethyl)-N-(2-(((1-(4-(trifluoromethyl)phenyl)pentylidene)amino)oxy)ethyl)nitrous amide. Synchemia is the leading manufacturing and exporter of N-Nitroso Fluvoxamine EP Impurity K . We supply N-Nitroso Fluvoxamine EP Impurity K with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142324 |
| CAS No | NA |
| Mol.F. | C16H18N4O5S |
| Mol.Wt. | 378.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142325 |
| CAS No | NA |
| Mol.F. | C16H20N4O6S |
| Mol.Wt. | 396.42 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142326 |
| CAS No | NA |
| Mol.F. | C24H25N5O6S |
| Mol.Wt. | 511.55 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142327 |
| CAS No | NA |
| Mol.F. | C15H20N4O4S |
| Mol.Wt. | 352.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142328 |
| CAS No | NA |
| Mol.F. | C16H13N3O3 |
| Mol.Wt. | 295.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142329 |
| CAS No | NA |
| Mol.F. | C13H19N3O5S |
| Mol.Wt. | 329.37 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142330 |
| CAS No | NA |
| Mol.F. | C13H16N2O4 |
| Mol.Wt. | 264.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142331 |
| CAS No | NA |
| Mol.F. | C32H37N7O9S2 |
| Mol.Wt. | 727.81 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142332 |
| CAS No | NA |
| Mol.F. | C32H38N8O11S2 |
| Mol.Wt. | 774.82 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142333 |
| CAS No | NA |
| Mol.F. | C48H55N11O14S3 |
| Mol.Wt. | 1106.21g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142334 |
| CAS No | NA |
| Mol.F. | C31H38N8O9S2 |
| Mol.Wt. | 730.81 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142335 |
| CAS No | NA |
| Mol.F. | C48H56N12O16S3 |
| Mol.Wt. | 1153.22 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142336 |
| CAS No | NA |
| Mol.F. | C17H20N4O7S |
| Mol.Wt. | 424.43 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142337 |
| CAS No | NA |
| Mol.F. | C21H18N4O4S |
| Mol.Wt. | 422 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142338 |
| CAS No | NA |
| Mol.F. | C8H11N3O4S |
| Mol.Wt. | 245.25 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142339 |
| CAS No | NA |
| Mol.F. | C13H8N2O2 |
| Mol.Wt. | 224.22 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |